Leadership team data not yet available for this company.
We're expanding our GCC coverage — check back soon.
No announcements yet.
See Data Freshness Monitor for platform-wide data quality.
Insufficient data
0/12 dimensions populated
SouqData provides data for informational purposes only. This does not constitute financial advice, a personal recommendation, or an offer to buy or sell any security. Information may contain errors or be outdated. Always verify data independently and consult a licensed financial adviser before making investment decisions.
Get unlimited access to 180+ insight pages, AI copilot, deep research reports, watchlists, portfolio tracking, and the full 210-column screener across 11 MENA exchanges.
| Company | Market cap (USD) | Dividend yield | Governance | Shariah |
|---|---|---|---|---|
| GlaxoSmithKline S.A.E. (BIOC) | $101M | — | — | — |
| Edita Food Industries SAE (EFID · EGX) | $694M | — | — | Non-compliant |
| Juhayna Food Industries (JUFO · EGX) | $590M | — | — | Non-compliant |
| GB Corp (GBCO · EGX) | $529M | — | — | Non-compliant |
| MM Group for Industry & International Trade (MTIE · EGX) | $274M | — | — | — |
| Ibnsina Pharma (ISPH · EGX) | $223M | — | — | Non-compliant |
Auto-generated peer set — same GICS sector, comparable market-cap band. Governance score is the unified 8-factor model (independence, board size, CEO/chair separation, attendance, auditor, credentials, committees, pay transparency). Shariah uses AAOIFI Standard No. 21. View all 182 sector peers.
